For patients considering tirzepatide-based medical weight loss, we recommend starting with a physician-guided consultation at our Sherman Oaks medical spa so your plan is built around safety, tolerability, and long-term outcomes.
With this compound, weight losses of up to 22% are generated in obese individuals [42], and several of the phase III SURPASS trials of patients with T2DM have shown reductions of HbA 1c to values at or below 5.7% (a completely normal value) in more than 50% of the patients, accompanied by weight losses in the order of 12% [43]
Combined with the Precision Peptide Genetic Test, microdose therapy plus genetic guidance often achieves robust weight loss without the need for additional appetite suppressants or stimulants
The closer to the center a drug is, the closer to launch
Aids in muscle preservation
Storage 4C, sealed storage, away from moisture and light * In solvent : -80C, 6 months